We are live on ! Find out more
NLVP

New Leaf Venture Partners Portfolio holdings

AUM $43M
1-Year Est. Return 25.55%
This Fund
S&P 500
This Quarter Est. Return
+93.87%
1 Year Est. Return
-25.55%
3 Year Est. Return
+17.13%
5 Year Est. Return
+114.46%
10 Year Est. Return
+1,011.57%
AUM
$124M
AUM Growth
+$46.3M
Cap. Flow
+$2.14M
Cap. Flow %
1.72%
Top 10 Hldgs %
99.62%
Holding
12
New
–
Increased
1
Reduced
2
Closed
–

Top Buys

Rank Stock Value
1
HARP
Harpoon Therapeutics, Inc. Common Stock
HARP
+$12.1M

Top Sells

Rank Stock Value
1
DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
+$8.07M
2
COGT icon
Cogent Biosciences
COGT
+$1.92M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ARVN icon
1
Arvinas
ARVN
$524M
$53.1M 42.75%
1,289,521
– –
HARP
2
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$21.1M 17.03%
1,859,168
+1,543,500
+489% +$12.1M
EWTX icon
3
Edgewise Therapeutics
EWTX
$4.33B
$17M 13.69%
1,553,661
– –
DCPH
4
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$9.31M 7.5%
576,975
-632,596
-52% -$8.07M
RLYB icon
5
Rallybio
RLYB
$86.1M
$7.89M 6.36%
412,700
– –
CRNX icon
6
Crinetics Pharmaceuticals
CRNX
$8.86B
$5.02M 4.04%
141,000
– –
RCKT icon
7
Rocket Pharmaceuticals
RCKT
$356M
$3.54M 2.85%
118,242
– –
ALEC icon
8
Alector
ALEC
$167M
$2.71M 2.18%
339,569
– –
PASG icon
9
Passage Bio
PASG
$15.4M
$2.52M 2.03%
124,896
– –
COGT icon
10
Cogent Biosciences
COGT
$6.82B
$1.47M 1.19%
250,765
-250,765
-50% -$1.92M
XFOR icon
11
X4 Pharmaceuticals
XFOR
$364M
$281K 0.23%
11,167
– –
ITRM
12
DELISTED
Iterum Therapeutics
ITRM
$191K 0.15%
97,084
– –

Similar funds

BAM
Broadcrest Asset Management Winter Park, Florida $44.1M AUM 4.51% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
WCPI
Wynnchurch Capital Partners IV Rosemont, Illinois $44.8M AUM 11.91% 1-Year Est. Return
WAMC
Western Asset Management Company Pasadena, California $45.2M AUM 6.96% 1-Year Est. Return
CC
Corton Capital Carrying Place, Ontario, Canada $40.7M AUM 52.32% 1-Year Est. Return
CIEP
Constellation Investimentos e Participacoes Sao Paulo, Brazil $46.7M AUM 23.3% 1-Year Est. Return
IPI
Inflection Point Investments London, United Kingdom $46.9M AUM 18.35% 1-Year Est. Return
VSAM
Value Star Asset Management Hong Kong $49.2M AUM 60.1% 1-Year Est. Return

New Leaf Venture Partners's Q4 2023 Portfolio in Review

As of Q4 2023, New Leaf Venture Partners held 12 positions worth $124M, up 59% from $77.9M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q4 2023: portfolio turnover was 0%. New Leaf Venture Partners opened no new positions and made no exits, leaving the 12-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • New Leaf Venture Partners added most to Harpoon Therapeutics, Inc. Common Stock in Q4 2023, an estimated $12.1M increase.
  • New Leaf Venture Partners's biggest Q4 2023 reduction was Deciphera Pharmaceuticals, Inc. Common Stock, cutting an estimated $8.07M.
  • New Leaf Venture Partners's ten largest holdings make up 100% of its $124M portfolio in Q4 2023.
  • New Leaf Venture Partners opened 0 new positions and closed 0 in Q4 2023.
  • New Leaf Venture Partners's portfolio value rose 59% quarter-over-quarter to $124M.

Based on New Leaf Venture Partners's 13F filing for Q4 2023, filed 14 Feb 2024.